Veropharm

What Veropharm does

Veropharm (Верофарм) is one of the leading Russian pharmaceutical manufacturers, established in 1997 and operating as a wholly-owned subsidiary of Abbott Laboratories. The company manufactures and sells more than 200 pharmaceutical products and medical devices, segmented across a dedicated hospital product line (госпитальная продукция) for institutional healthcare procurement and a retail product line (розничная продукция) distributed through Russian pharmacy networks via the AbbottPro.ru portal. Therapeutic coverage spans multiple areas including oncology, with specialized manufacturing capability using isolator systems and HEPA filtration for handling highly active substances.

Production is conducted across three GMP-compliant manufacturing facilities located in Belgorod, Volginsky (Vladimir region), and Voronezh, all certified to international GMP, ISO 9001, and ISO 13485 standards. Veropharm employs more than 2,000 people according to its own website (firmographics range: 5,001-10,000), with its central office headquartered in Moscow. The company's core technology stack is physical industrial manufacturing rather than software; it does not expose APIs, SDKs, or digital products.

The business model is straightforward B2B and B2B2C pharmaceutical manufacturing. Veropharm generates revenue through one-time sales of pharmaceutical products to two primary channels: institutional hospital procurement (enterprise sales motion with field sales teams engaging healthcare providers) and retail pharmacy distribution (mid-market channel/reseller motion). Pricing is not publicly disclosed and varies by channel. The company also invests in medical professional engagement, organizing and financing scientific-educational events across Russian cities, and runs the "A2B: Academy for Business" talent development program in partnership with four leading Russian universities (IGHTU, SPHFA, BelGU, VlGU) since 2015. Geographic operations are entirely domestic, concentrated in Central Russia with no disclosed international expansion.

Name

Veropharm

Legal name

АО «Верофарм»

Website

https://veropharm.ru

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Veropharm is a leading Russian pharmaceutical manufacturer and wholly-owned Abbott subsidiary, producing 200+ medicines and medical devices across hospital and retail channels via three GMP-certified plants in Belgorod, Volginsky, and Voronezh, serving Russian healthcare providers and pharmacies.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD), Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Pharmaceutical manufacturing
• Generic drugs
• Hospital pharmaceuticals
• Medical devices
• Oncology drugs

Headquarters

HQ city

Moscow

HQ country

Russia

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Veropharm generates revenue through the manufacture and sale of pharmaceutical products and medical devices. The company portfolio includes over 200 product names covering various therapeutic areas. Products are distributed through hospital procurement and retail pharmacy channels.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Veropharm manufactures and sells a portfolio of more than 200 pharmaceutical products and medical devices in Russia, split into two commercial lines: Hospital Products (Госпитальная продукция) for institutional healthcare buyers and Retail Products (Розничная продукция) for pharmacy distribution. The company operates three GMP-compliant production facilities in Belgorod, Volginsky (Vladimir region), and Voronezh, and is a wholly-owned subsidiary of Abbott Laboratories.

Product overview

Veropharm (group of Abbott) is one of the leading Russian pharmaceutical manufacturers with a product portfolio of over 200 pharmaceutical products and medical devices. The company operates through three distinct product lines: Hospital Products (Госпитальная продукция) for institutional healthcare providers, Retail Products (Розничная продукция) distributed through pharmacies, and specialized oncological drug manufacturing. The company operates three manufacturing facilities located in Belgorod, Volginsky (Vladimir region), and Voronezh, all equipped to international GMP standards.

Differentiator

Problem solved

Functional benefit

Products and services

• Hospital Products (Госпитальная продукция)

Quantifiable outcome

• More than 200 pharmaceutical products and medical devices in portfolio

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and supporting.

• Abbott LaboratoriescoreStrategic or Co-development Partner · 1 January 2015Veropharm is a subsidiary of Abbott Laboratories, an international healthcare company. This ownership provides Veropharm with access to global pharmaceutical expertise, international quality standards, and Abbott's product portfolio and technologies.
• Ivanovo State Chemical-Technological University (IGHTU)supportingStrategic or Co-development PartnerPartnership for professional development and training of future pharmaceutical industry specialists as part of Abbott's A2B: Academy for Business program.
• Saint Petersburg State Chemical-Pharmaceutical Academy (SPHFA)supportingStrategic or Co-development PartnerPartnership for professional development and training of future pharmaceutical industry specialists as part of Abbott's A2B: Academy for Business program.
• Belgorod State National Research University (BelGU)supportingStrategic or Co-development PartnerPartnership for professional development and training of future pharmaceutical industry specialists as part of Abbott's A2B: Academy for Business program.
• Vladimir State University named after A.G. and N.G. Stoletovs (VlGU)supportingStrategic or Co-development PartnerPartnership for professional development and training of future pharmaceutical industry specialists as part of Abbott's A2B: Academy for Business program.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Pharmstandard: Largest Russian pharmaceutical manufacturer producing branded and generic drugs across similar therapeutic categories. Directly comparable as a domestic Russian pharma manufacturer with hospital and retail distribution.
• Valenta Pharm: Russian pharmaceutical manufacturer with broad prescription and OTC portfolio distributed through retail pharmacy chains. Closely comparable in scale, product mix, and Russia-focused B2B/retail model.
• OTCPharm: Russian pharmaceutical company producing OTC and Rx medicines distributed via retail pharmacy networks. Comparable in domestic Russian manufacturing footprint and retail-channel focus.
• Biocad: Russian biotechnology company manufacturing pharmaceutical products including biologics and oncology therapies. Comparable as a Russia-based pharma manufacturer with specialty drug manufacturing capabilities.
• Grotex: Russian pharmaceutical manufacturer producing a broad portfolio of generics and OTC products. Comparable in domestic generic manufacturing focus and pharmacy-channel distribution.

Regional players

• Polpharma: Polish pharmaceutical manufacturer with a broad generics portfolio across Central/Eastern Europe. Comparable as a regional generic pharma manufacturer targeting similar therapeutic areas, though operating in different geography.

Broad incumbents

• STADA Arzneimittel: European-focused generics and specialty pharmaceutical company with broad product portfolio. Comparable as a multi-country generic/specialty manufacturer, though larger and more internationally diversified.
• KRKA: Slovenian generic pharmaceutical manufacturer with a broad product portfolio across Central and Eastern Europe. Comparable in generics focus and CEE market orientation, though with international footprint.
• Teva Pharmaceutical Industries: World's largest generic drug manufacturer with broad portfolio across multiple therapeutic areas. Comparable in generic manufacturing and multi-channel distribution, though operating at much greater global scale.
• Sandoz (Novartis): Global leader in generics and biosimilars spun out of Novartis. Comparable as a large-scale generics manufacturer with broad portfolio across multiple therapeutic categories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/veropharm-oao

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Veropharm